Associations between alcohol demand, delayed reward discounting, and high-intensity drinking in a diverse emerging adult sample.


Journal

Experimental and clinical psychopharmacology
ISSN: 1936-2293
Titre abrégé: Exp Clin Psychopharmacol
Pays: United States
ID NLM: 9419066

Informations de publication

Date de publication:
Aug 2023
Historique:
pmc-release: 01 08 2024
medline: 19 7 2023
pubmed: 15 5 2023
entrez: 15 5 2023
Statut: ppublish

Résumé

The high-intensity drinking threshold (HID; 8+/10+ drinks for women/men) is more strongly associated with significant alcohol-related health consequences than the more common heavy episodic drinking threshold (HED; 4+/5+ drinks for women/men). Behavioral economic measures of alcohol reward value (demand) and delayed reward discounting (DRD) have shown associations with other alcohol-related risk behaviors and may contribute to efforts to identify individuals who are at risk for HID from the larger subgroup of at-risk drinkers who engage in HED. Logistic regression analyses tested if alcohol demand and DRD were associated with HID in a sample of 477 emerging adults who reported recent heavy drinking. Receiver operating curve (ROC) analyses were conducted to test these variables' ability to classify HID group membership and to select an optimal cutoff score. In logistic regression analyses controlling for typical weekly drinking, demographics, and other variables associated with HID, participants reporting higher demand intensity (amount of alcohol purchased when price is zero; Adjusted Odds Ratio (AOR) = 20.27, 95% CI [5.71, 71.91]) and lower demand elasticity (sensitivity of alcohol consumption to increases in cost; AOR = .29, 95% CI [.11, 72]) were more likely to report HID relative to HED.

Identifiants

pubmed: 37184944
pii: 2023-72240-001
doi: 10.1037/pha0000653
pmc: PMC10527522
mid: NIHMS1911587
doi:

Substances chimiques

Ethanol 3K9958V90M

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

829-838

Subventions

Organisme : NIAAA NIH HHS
ID : R01 AA024930
Pays : United States
Organisme : NIH HHS
Pays : United States

Références

Psychol Addict Behav. 2011 Dec;25(4):595-604
pubmed: 21988480
JAMA. 2003 Jan 1;289(1):70-5
pubmed: 12503979
J Consult Clin Psychol. 2015 Dec;83(6):1033-43
pubmed: 26167945
Exp Clin Psychopharmacol. 2006 May;14(2):219-27
pubmed: 16756426
Behav Processes. 2017 Aug;141(Pt 1):33-41
pubmed: 28373056
Annu Rev Clin Psychol. 2014;10:641-77
pubmed: 24679180
Curr Addict Rep. 2020 Sep;7(3):280-290
pubmed: 33747711
Addict Behav. 2019 Nov;98:106044
pubmed: 31330464
JAMA Pediatr. 2013 Nov;167(11):1019-25
pubmed: 24042318
Alcohol Clin Exp Res. 2012 Apr;36(4):716-24
pubmed: 22017303
J Exp Anal Behav. 2015 Jan;103(1):125-40
pubmed: 25533393
Alcohol Clin Exp Res. 2020 Oct;44(10):2130-2140
pubmed: 32965723
Psychol Addict Behav. 2022 Sep;36(6):607-618
pubmed: 35084904
Addiction. 2012 Dec;107(12):2109-14
pubmed: 22690907
Addiction. 2021 Oct;116(10):2635-2650
pubmed: 33338263
Exp Clin Psychopharmacol. 2021 Apr;29(2):191-202
pubmed: 32730058
Alcohol Clin Exp Res. 2016 Apr;40(4):672-85
pubmed: 26993151
J Stud Alcohol. 2006 Jan;67(1):169-77
pubmed: 16536141
Subst Abus. 2016 Oct-Dec;37(4):597-605
pubmed: 27092592
Exp Clin Psychopharmacol. 2009 Dec;17(6):396-404
pubmed: 19968404
Addiction. 2022 Jul;117(7):1887-1896
pubmed: 35112741
Alcohol Clin Exp Res. 2021 May;45(5):1078-1090
pubmed: 33797768
Psychol Addict Behav. 2022 Sep;36(6):581-594
pubmed: 36066869
Psychol Addict Behav. 2008 Sep;22(3):349-61
pubmed: 18778128
Exp Clin Psychopharmacol. 1998 Aug;6(3):292-305
pubmed: 9725113
Alcohol Res. 2013;35(2):201-18
pubmed: 24881329
JAMA Pediatr. 2023 Mar 1;177(3):286-293
pubmed: 36716022
Alcohol Clin Exp Res. 2016 Feb;40(2):256-9
pubmed: 26842244
Exp Clin Psychopharmacol. 2015 Oct;23(5):377-86
pubmed: 26147181
Alcohol Clin Exp Res. 2015 May;39(5):896-904
pubmed: 25871945
Addict Behav. 2017 Nov;74:134-139
pubmed: 28628871
Alcohol Clin Exp Res. 2017 Oct;41(10):1754-1759
pubmed: 28800154
Psychopharmacology (Berl). 2011 Aug;216(3):305-21
pubmed: 21373791
Addiction. 2017 Jan;112(1):51-62
pubmed: 27450931
Alcohol Clin Exp Res. 2021 Sep;45(9):1821-1828
pubmed: 34342001
Exp Clin Psychopharmacol. 2014 Jun;22(3):198-210
pubmed: 24749779
J Consult Clin Psychol. 1990 Dec;58(6):805-10
pubmed: 2292630
Exp Clin Psychopharmacol. 2014 Jun;22(3):222-8
pubmed: 24708144
Health Psychol. 2015 Dec;34S:1209-19
pubmed: 26651462
Alcohol Res. 2018;39(1):49-55
pubmed: 30557148
Psychol Addict Behav. 2022 Sep;36(6):664-677
pubmed: 34914406
JAMA Netw Open. 2022 Oct 3;5(10):e2238880
pubmed: 36301540
Am J Public Health. 1993 Jun;83(6):830-7
pubmed: 8498620
J Stud Alcohol Drugs. 2019 May;80(3):331-339
pubmed: 31250798
Psychol Addict Behav. 2021 Jun;35(4):415-423
pubmed: 33630617
J Stud Alcohol Drugs. 2013 May;74(3):490-9
pubmed: 23490580
J Consult Clin Psychol. 1985 Apr;53(2):189-200
pubmed: 3998247
J Consult Clin Psychol. 2004 Apr;72(2):155-64
pubmed: 15065951
Addiction. 2017 Jan;112(1):82-93
pubmed: 27514864
J Abnorm Psychol. 2010 Feb;119(1):106-14
pubmed: 20141247
Drug Alcohol Depend. 2020 Mar 1;208:107838
pubmed: 31954948
JAMA Pediatr. 2013 Nov;167(11):996-8
pubmed: 24042186

Auteurs

Ulysses C Savage (UC)

Department of Psychology, University of Memphis.

James MacKillop (J)

Department of Psychiatry and Behavioural Neurosciences, McMaster University.

James G Murphy (JG)

Department of Psychology, University of Memphis.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH